Skip to product information
1 of 2

My Store

Tirzepatide 40mg

Tirzepatide 40mg

Regular price $125.00 USD
Regular price Sale price $125.00 USD
Sale Sold out
Shipping calculated at checkout.
Quantity

Precision-Dosed Dual GIP/GLP-1 Agonist for Targeted Research

Tirzepatide 40mg is a precision-dosed dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist designed for focused metabolic research. This 40mg supply provides researchers with an ideal quantity for targeted studies in glucose regulation, weight management, and metabolic health without excess material.

Why Researchers Choose Tirzepatide 40mg:

  • Precision Dosing: 40mg provides the perfect amount for focused research projects and pilot studies
  • Budget-Friendly: Cost-effective option for laboratories with specific research objectives
  • Dual Mechanism Innovation: First-in-class dual GIP/GLP-1 receptor agonist for studying synergistic effects
  • Minimal Waste: Ideal quantity for targeted experiments without excess material
  • Enhanced Potency: Superior efficacy compared to single-receptor agonists
  • Flexible Research: Perfect for proof-of-concept studies and preliminary investigations
  • Quality Assurance: Same pharmaceutical-grade purity (≥98%) as larger formats
  • Quick Start: Smaller quantity allows researchers to begin studies immediately

Ideal Research Applications:

Perfect for laboratories conducting focused metabolic research, pilot studies, proof-of-concept experiments, and targeted investigations. Tirzepatide 40mg is particularly valuable for researchers who:

  • Are initiating new research programs in metabolic health
  • Need to validate experimental protocols before scaling up
  • Want to explore dual incretin receptor mechanisms
  • Are conducting comparative studies with other peptides
  • Require precise quantities for specific experimental designs
  • Are working with budget constraints while maintaining quality

Key Research Areas:

  • Dual incretin receptor activation and synergistic metabolic effects
  • Body weight regulation and appetite suppression mechanisms
  • Glucose-dependent insulin secretion pathways
  • Satiety signaling and food intake regulation
  • Cardiovascular benefits of metabolic interventions
  • Beta-cell function and glucose homeostasis
  • Lipid metabolism and fat distribution
  • Energy expenditure and metabolic rate

Technical Specifications:

  • Quantity: 40mg (precision research supply)
  • Type: Dual GIP/GLP-1 receptor agonist
  • Structure: 39 amino acid synthetic peptide
  • Form: Lyophilized powder for reconstitution
  • Purity: ≥98% (HPLC verified)
  • Molecular Weight: ~4813 Da
  • Storage: Store at 2-8°C before reconstitution; -20°C after reconstitution
  • Solubility: Reconstitute with bacteriostatic water
  • Stability: Enhanced stability profile with C20 fatty acid modification
  • Quality: Pharmaceutical-grade for reliable results

Research Advantages:

Tirzepatide represents a breakthrough in incretin-based research, combining GIP and GLP-1 receptor activation to produce superior metabolic outcomes. The 40mg supply provides researchers with a focused quantity that's perfect for targeted studies and pilot investigations.

Unique Mechanism: Unlike single-receptor agonists, Tirzepatide activates both GIP and GLP-1 receptors simultaneously, leading to enhanced insulin secretion, reduced glucagon levels, delayed gastric emptying, and significant appetite suppression. The dual activation creates synergistic effects that exceed the sum of individual receptor stimulation.

Clinical Relevance: Tirzepatide has demonstrated remarkable efficacy in clinical trials, with weight loss results surpassing other available treatments. This makes it an essential tool for researchers investigating next-generation metabolic therapeutics and understanding the mechanisms behind superior clinical outcomes.

Perfect for Pilot Studies: The 40mg quantity is ideal for researchers who want to explore tirzepatide's mechanisms before committing to larger research programs. It provides sufficient material for initial experiments, protocol optimization, and preliminary data collection.

Cost-Effective Entry Point: For laboratories new to tirzepatide research or working with limited budgets, the 40mg format offers an accessible entry point while maintaining the same high-quality standards as larger quantities.

Research Flexibility: This quantity allows researchers to test multiple experimental conditions, compare different dosing regimens, and validate findings before scaling up to more extensive studies.

Important Disclaimer: This product is sold exclusively for research and laboratory purposes. Not intended for human consumption, therapeutic use, weight loss applications, or veterinary use. For in vitro and animal research only.

*Price per vial.
*This product is in powder form and is not reconstituted.
*For research purposes only.
*Tested at 99% purity.
*Free shipping.
*All sales final.

View full details